Stay updated on Safety of PBCAR20A in NHL/CLL Clinical Trial

Sign up to get notified when there's something new on the Safety of PBCAR20A in NHL/CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of PBCAR20A in NHL/CLL Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    0.8%
    Check dated 2025-05-08T13:45:40.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.5%
    Check dated 2025-05-01T06:16:22.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2025-04-24T00:25:26.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant changes, including the removal of detailed descriptions of the PBCAR20A study protocol and key inclusion/exclusion criteria for participants, while retaining the study's name and revision number.
    Difference
    33%
    Check dated 2025-04-16T20:27:57.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.8%
    Check dated 2025-04-09T14:00:16.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The term 'Lymphosarcoma' has been removed and replaced with 'B-cell Lymphoma'.
    Difference
    0.6%
    Check dated 2025-04-02T00:06:16.000Z thumbnail image

Stay in the know with updates to Safety of PBCAR20A in NHL/CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of PBCAR20A in NHL/CLL Clinical Trial page.